{"id":"https://openalex.org/W2000836002","doi":"https://doi.org/10.1002/chir.530050713","title":"Enantiomeric conformers of the opioid agonist ketobemidone HCl in the crystal state","display_name":"Enantiomeric conformers of the opioid agonist ketobemidone HCl in the crystal state","publication_year":1993,"publication_date":"1993-01-01","ids":{"openalex":"https://openalex.org/W2000836002","doi":"https://doi.org/10.1002/chir.530050713","mag":"2000836002","pmid":"https://pubmed.ncbi.nlm.nih.gov/7902122"},"language":"en","primary_location":{"id":"doi:10.1002/chir.530050713","doi":"https://doi.org/10.1002/chir.530050713","is_oa":false,"landing_page_url":"https://doi.org/10.1002/chir.530050713","pdf_url":null,"source":{"id":"https://openalex.org/S67976470","display_name":"Chirality","issn_l":"0899-0042","issn":["0899-0042","1520-636X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chirality","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074254627","display_name":"Mark Froimowitz","orcid":"https://orcid.org/0000-0001-9126-8288","observed_orcids":["https://orcid.org/0000-0001-9126-8288"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I2801148111","display_name":"McLean Hospital","ror":"https://ror.org/01kta7d96","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801148111"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Mark Froimowitz","raw_affiliation_strings":["Alcohol and Drug Abuse Research Center, McLean Hospital, Harvard Medical School, Belmont, Massachusetts 02178-9106"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alcohol and Drug Abuse Research Center, McLean Hospital, Harvard Medical School, Belmont, Massachusetts 02178-9106","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I2801148111"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088782676","display_name":"Vivian Cody","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vivian Cody","raw_affiliation_strings":["Medical Foundation of Buffalo, Incorporated, Buffalo, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Foundation of Buffalo, Incorporated, Buffalo, New York","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5074254627"],"corresponding_institution_ids":["https://openalex.org/I136199984","https://openalex.org/I2801148111"],"apc_list":{"value":4030,"currency":"USD","value_usd":4030},"apc_paid":null,"fwci":0.7048,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.63487223,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"5","issue":"7","first_page":"560","last_page":"564"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10464","display_name":"Crystal structures of chemical compounds","score":0.8393999934196472,"subfield":{"id":"https://openalex.org/subfields/1604","display_name":"Inorganic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10464","display_name":"Crystal structures of chemical compounds","score":0.8393999934196472,"subfield":{"id":"https://openalex.org/subfields/1604","display_name":"Inorganic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10798","display_name":"Crystallography and molecular interactions","score":0.040800001472234726,"subfield":{"id":"https://openalex.org/subfields/1606","display_name":"Physical and Theoretical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12748","display_name":"Molecular spectroscopy and chirality","score":0.03460000082850456,"subfield":{"id":"https://openalex.org/subfields/1607","display_name":"Spectroscopy"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ketobemidone","display_name":"ketobemidone","score":0.996999979019165},{"id":"https://openalex.org/keywords/conformational-analysis","display_name":"conformational analysis","score":0.6420000195503235},{"id":"https://openalex.org/keywords/crystal-structure","display_name":"crystal structure","score":0.7059999704360962},{"id":"https://openalex.org/keywords/opioid-agonists","display_name":"opioid agonists","score":0.7269999980926514},{"id":"https://openalex.org/keywords/piperidine-derivatives","display_name":"piperidine derivatives","score":0.5860000252723694},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.8410000205039978},{"id":"https://openalex.org/keywords/centrosymmetric-crystal-structure","display_name":"centrosymmetric crystal structure","score":0.6579999923706055},{"id":"https://openalex.org/keywords/mm2-calculations","display_name":"MM2 calculations","score":0.6679999828338623}],"concepts":[{"id":"https://openalex.org/C18705241","wikidata":"https://www.wikidata.org/wiki/Q1128023","display_name":"Conformational isomerism","level":3,"score":0.9783678650856018},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8576911687850952},{"id":"https://openalex.org/C61276311","wikidata":"https://www.wikidata.org/wiki/Q624543","display_name":"Monoclinic crystal system","level":3,"score":0.7975785732269287},{"id":"https://openalex.org/C486523","wikidata":"https://www.wikidata.org/wiki/Q494483","display_name":"Enantiomer","level":2,"score":0.7098373174667358},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.6160325407981873},{"id":"https://openalex.org/C115624301","wikidata":"https://www.wikidata.org/wiki/Q895901","display_name":"Crystal structure","level":2,"score":0.5238789916038513},{"id":"https://openalex.org/C8010536","wikidata":"https://www.wikidata.org/wiki/Q160398","display_name":"Crystallography","level":1,"score":0.4984159469604492},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.48404091596603394},{"id":"https://openalex.org/C2780378348","wikidata":"https://www.wikidata.org/wiki/Q25351438","display_name":"Ring (chemistry)","level":2,"score":0.4833528697490692},{"id":"https://openalex.org/C32909587","wikidata":"https://www.wikidata.org/wiki/Q11369","display_name":"Molecule","level":2,"score":0.43963855504989624},{"id":"https://openalex.org/C2781462491","wikidata":"https://www.wikidata.org/wiki/Q410234","display_name":"Piperidine","level":2,"score":0.42122673988342285},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.12942850589752197},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.05282816290855408},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000701","descriptor_name":"Analgesics, Opioid","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D003460","descriptor_name":"Crystallization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008614","descriptor_name":"Meperidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D008614","descriptor_name":"Meperidine","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D008958","descriptor_name":"Models, Molecular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008968","descriptor_name":"Molecular Conformation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013237","descriptor_name":"Stereoisomerism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013816","descriptor_name":"Thermodynamics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018360","descriptor_name":"Crystallography, X-Ray","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/chir.530050713","doi":"https://doi.org/10.1002/chir.530050713","is_oa":false,"landing_page_url":"https://doi.org/10.1002/chir.530050713","pdf_url":null,"source":{"id":"https://openalex.org/S67976470","display_name":"Chirality","issn_l":"0899-0042","issn":["0899-0042","1520-636X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chirality","raw_type":"journal-article"},{"id":"pmid:7902122","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7902122","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chirality","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/6","display_name":"Clean water and sanitation","score":0.46000000834465027}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2064296487","display_name":null,"funder_award_id":"DA-04762","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G4440269492","display_name":"EFFECT OF CONFORMATION ON OPIOID AGONISTS/ANTAGONISTS","funder_award_id":"5r01da004762-03","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W284309151","https://openalex.org/W1967320840","https://openalex.org/W2000984231","https://openalex.org/W2015348124","https://openalex.org/W2016634408","https://openalex.org/W2021062049","https://openalex.org/W2023738502","https://openalex.org/W2035489288","https://openalex.org/W2035884704","https://openalex.org/W2038266555","https://openalex.org/W2052772948","https://openalex.org/W2053768394","https://openalex.org/W2055569402","https://openalex.org/W2070777570","https://openalex.org/W2075340963","https://openalex.org/W2085495642","https://openalex.org/W2088156020","https://openalex.org/W2095295940","https://openalex.org/W2155237578","https://openalex.org/W2415062947","https://openalex.org/W4206402978","https://openalex.org/W4213057929"],"related_works":["https://openalex.org/W2118187556","https://openalex.org/W2088661887","https://openalex.org/W2155237578","https://openalex.org/W1976844220","https://openalex.org/W2950808081","https://openalex.org/W2006214444","https://openalex.org/W2027090766","https://openalex.org/W2023738502","https://openalex.org/W2060887424","https://openalex.org/W1995626581"],"abstract_inverted_index":{"A":[0],"crystal":[1,16,40,125],"of":[2,77,87,99,113,118],"the":[3,26,39,47,53,73,78,84,88,92,96,115],"potent":[4],"opioid":[5,106],"agonist":[6],"ketobemidone":[7],"[1-methyl-4-(3-hydroxyphenyl)-4-propionylipiperidine]":[8],"HCl":[9],"was":[10,17],"analyzed":[11],"by":[12],"X-ray":[13],"crystallography.":[14],"The":[15,56,111],"monoclinic,":[18],"space":[19],"group":[20],"P2(1)/n":[21],"with":[22,31],"four":[23],"molecules":[24],"in":[25,45,123],"unit":[27],"cell.":[28],"In":[29],"agreement":[30],"MM2":[32],"calculations":[33],"(J.":[34],"Med.":[35],"Chem.":[36],"25:1127-1133,":[37],"1982),":[38],"contains":[41],"mirror":[42],"image":[43],"conformers":[44,57,98],"which":[46,103],"phenyl":[48],"ring":[49],"is":[50,67,127],"equatorial":[51],"to":[52,69],"piperidine":[54],"ring.":[55],"are":[58,62],"enantiomers":[59,117],"since":[60,80],"they":[61],"not":[63],"superimposable.":[64],"One":[65],"conformer":[66,86,94],"predicted":[68],"be":[70],"responsible":[71],"for":[72],"typical":[74],"morphine-like":[75,89],"activity":[76],"compound":[79],"it":[81],"closely":[82],"matches":[83],"preferred":[85,97],"(+)-phenylmorphan":[90],"whereas":[91],"other":[93],"resembles":[95],"(+)-beta-prodine":[100],"and":[101],"(-)-phenylmorphan":[102],"have":[104],"atypical":[105],"properties":[107],"and/or":[108],"structure-activity":[109],"relationships.":[110],"importance":[112],"considering":[114],"conformational":[116],"a":[119],"nonchiral":[120],"receptor":[121],"ligand":[122],"centrosymmetric":[124],"structures":[126],"emphasized.":[128]},"counts_by_year":[{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}